LPPC has been shown to be an excellent drug transporter, capable of delivering large quantities of encapsulated molecules across the cell membrane quickly, which would likely explain the benefits observed by LPPC/TAM treatment in all breast cancer cells containing ER-positive and ER-negative cells. This evidence concerns the gene ESR1 and breast cancer.